Soterix Medical Inc. (SMI) was formed to develop and deploy innovative medical treatments focused on neuropsychiatric and neurological disorders and rehabilitation. Founded in 2008, SMI is the world leader in clinical trials for non-invasive neuromodulation working with over 450 medical centers in the US and worldwide. SMI has licensed and developed a comprehensive intellectual property portfolio that includes High-Definition transcranial Direct Current Stimulation (HD-tDCS), Limited Total Energy tDCS (LTE-tDCS), and Neurotargeting. From the most targeted non-invasive clinical systems to the most portable units, Soterix Medical provides clinicians and patients with unique and adaptable solutions. Ongoing Phase I, II, IIb, and III trials use investigational devices that are regulated/limited by US or Federal law. SMI is proudly based in the Tri-state area with international distributors in all major markets.
At Soterix Medical, Engineering Serving Humanity means that we are committed to bring the most advanced medical technology into the hands of people who need it. The commitment underpins everything we do.
1480 U.S. 9N,WOODBRIDGE, NJ 07095
ISO 13485:2016 certifiedMDSAP certifiedFDA Registered Facility
The NIRSIT System
The NIRSIT LITE
The NIRSIT Software
The NIRSIT EYE PC tool is a measurement software that comes with all of our NIRSIT devices. It helps save the measured data and change or extract the data into a functional CSV format. The NIRSIT EYE PC can receive external event markers from other task programs. The tool also synchronizes the data with markers and changes the data to a suitable data form for analysis.
NIRSIT Analysis Tool provides a variety of functions that allow you to easily analyze and process measured data in real time.
Proprietary analysis tool that is easy-to-use and includes typical fNIRS analysis:
Monitor the level and distribution of subject’s cerebral oxygen saturation while performing pre-programmed tasks.
Perform real-time cerebral oxygen saturation monitoring in two modes: